Simultaneous Determination of Lidocaine, Proline and Lomefloxacin in Human Urine by CE with Electrochemiluminescence Detection

A nanocomposite fluorescent probe of polyaniline, graphene oxide and quantum dots incorporated into highly selective polymer for lomefloxacin detection

A nanocomposite fluorescent probe based on fluorescence quenching was fabricated and utilized for the detection of lomefloxacin. The fabricated probe integrated the high sensitivity of quantum dots, the excellent selectivity of molecularly imprinted polymer and the high adsorption affinity of graphene oxide and polyaniline. The probe exhibited good sensitivity, high specificity, and rapidity for lomefloxacin monitoring. Fluorescence emission was reduced linearly by lomefloxacin from 0.10 to 50.0 μg L^-1 and the probe exhibited a low limit of detection of 0.07 μg L^-1. The nanooptosensor successfully detected lomefloxacin in milk, chicken meat and egg samples. Recoveries were obtained in the range of 81.5-99.6% and the RSDs were below 7%. The results of this method agreed well with results of HPLC but provided higher sensitivity. This easily fabricated nanocomposite probe could be developed into a highly sensitive and selective optosensor to detect other organic compounds in various complex samples.

Silver nanoparticles for the visual detection of lomefloxacin in the presence of cystine

A novel optical sensors for lomefloxacin based on the plasma resonance properties of silver nanoparticles (AgNPs) for the first time. The hydrogen bonds and electrostatic force between the lomefloxacin and AgNPs could induce the change in color and absorption spectra of AgNPs suspension, which provided a theoretical basis for the optical detection of lomefloxacin. In addition, we made the AgNPs-lomefloxacin detection system reach the critical point of discoloration by adding cystine to improve the sensitivity. Furthermore, the influence of some factors such as temperature, reaction time and pH on the AgNPs-lomefloxacin detection system was investigated. The results of UV-vis spectra showed that the absorption ratio (A₅₂₀/A₃₉₅) was linear with the concentration of lomefloxacin in the range from 0.2 to 5 μmol/L with linear coefficients of 0.991. The proposed method can be applied to detecting lomefloxacin with an ultralow detection limit of 0.6 μmol/L without any complicated instruments and complex pretreatment. The selectivity of AgNPs-lomefloxacin detection system is proved excellent by comparing with other ions and analytes in urine. The method in our study is appropriate to be used to monitor quantitatively entecavir in human urine owing to its rapid response rate, visible color changes, wide linear range and excellent selectivity.

Chromatographic Determination of Aminoacridine Hydrochloride, Lidocaine Hydrochloride and Lidocaine Toxic Impurity in Oral Gel

Two sensitive and selective analytical methods were developed for simultaneous determination of aminoacridine hydrochloride and lidocaine hydrochloride in bulk powder and pharmaceutical formulation. Method A was based on HPLC separation of the cited drugs with determination of the toxic lidocaine-related impurity 2,6-dimethylaniline. The separation was achieved using reversed-phase column C18, 250 × 4.6 mm, 5 µm particle size and mobile phase consisting of 0.05 M disodium hydrogen phosphate dihydrate (pH 6.0 ± 0.2 adjusted with phosphoric acid) and acetonitrile (55 : 45, v/v). Quantitation was achieved with UV detection at 240 nm. Linear calibration curve was in the range of 1.00-10.00, 13.20-132.00 and 1.32-13.20 µg mL(-1) for aminoacridine hydrochloride, lidocaine hydrochloride and 2,6-dimethylaniline, respectively. Method B was based on TLC separation of the cited drugs followed by densitometric measurement at 365 nm on the fluorescent mode for aminoacridine hydrochloride and 220 nm on the absorption mode for lidocaine hydrochloride. The separation was carried out using ethyl acetate-methanol-acetic acid (65 : 30 : 5 by volume) as a developing system. The calibration curve was in the range of 25.00-250.00 ng spot(-1) and 0.99-9.90 µg spot(-1) for aminoacridine hydrochloride and lidocaine hydrochloride, respectively. The results obtained were statistically analyzed and compared with those obtained by applying the manufacturer's method.